$11.060
+0.415 (+3.75%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KROS por análisis de gráficos similares
Alphio's KROS stock price prediction model matches the current Keros Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.36 (-0.31%). The 1-week path is $11.47 (+0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Keros Therapeutics Inc?
Keros Therapeutics Inc is not a good buy right now due to its current price of $10.66 being significantly below analyst targets, with BofA at $17 and Wells Fargo at $18. The company has a high forward P/E of 48.78, indicating potential overvaluation, and the RSI is at 29.465, suggesting it is oversold. Additionally, the stock has seen a 42.50% decline year-to-date, reflecting ongoing market concerns. The main risk is the negative earnings trend, with EPS reported at -1.45, which raises questions about profitability and future growth.
KROS cerró en $11.06 el Monday, tras subir +3.75%
Keros Therapeutics Inc (KROS) last closed at $11.4, gaining +3.07%. These facts feed the 1-day and 1-week KROS price prediction above.
Factores de la previsión
Los factores de la previsión de Keros Therapeutics Inc (KROS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KROS, ordenadas por similitud.
Análisis de estacionalidad de KROS
Historically the probability of a positive October return for KROS is 43.33%. November offers the highest probability of a positive month at 92.31%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.